
Shandong Weifang Rainbow Chemical Co., Ltd.
Rainbow Chemical
Rainbow Chemical (Shandong Weifang Rainbow Chemical Co., Ltd.) is China's premier independent agrochemical manufacturer and a rapidly ascending global force in crop protection, founded in 2005 in Shandong Province. With 2025 annual revenue of RMB 14.688 billion (~US$2.1 billion)—representing a 10.47% year-on-year growth—and net profit surging 132.07% to RMB 1.045 billion, the company has firmly established itself as the 10th largest agrochemical manufacturer globally. Listed on the Shenzhen Stock Exchange (SZSE: 301035), Rainbow Chemical has deliberately transformed from a traditional Chinese contract manufacturer into a true global brand manufacturer with in-house synthesis, formulation, registration, and direct farmer-facing distribution capabilities spanning 100+ countries.
Strengths:
• Self-owned heavy-asset manufacturing base: Rainbow operates multi-10,000-tonne annual capacity synthesis plants at its Weifang Binhai mega-complex in Shandong, fully controlling the entire chain from technical-grade active ingredient production to downstream formulation compounding. This vertical integration captured a 31.68% gross margin on its direct B2C segment in 2025, far exceeding industry averages for pure formulators.
• Global direct-market penetration ('Model Farm' strategy): Through its unique 'Team + Platform + Innovation' model, Rainbow has bypassed traditional distribution channels to directly serve end-use farmers and retailers in 40+ countries. Its B2C segment revenue share climbed to 43.44% in 2025, transforming Rainbow from a backend supplier into a pricing-power brand in key markets across Latin America, Africa, and Asia.
• Strategic overseas asset acquisition: In 2025, Rainbow acquired Spanish agrochemical firm Sarabia S.A. for €32 million, gaining immediate EU manufacturing registration, established distribution networks, and a production foothold in one of the world's most regulated agricultural chemical markets—a gateway that would take a decade to build organically.
• Diversification beyond herbicides: While historically dominated by herbicides (70%+ of revenue), Rainbow achieved a breakthrough in 2025: insecticide and fungicide revenue share increased to 30.15%, and the newly launched 'RainbowBio' biological product line began commercialization across multiple continents, reducing business concentration risk.
Weaknesses:
• Extreme foreign exchange exposure: With 99.18% of revenue derived from outside China, Rainbow's earnings are acutely sensitive to RMB appreciation and currency volatility in key markets including Brazil (BRL), Argentina (ARS), and Nigeria (NGN), creating unpredictable margin compression risks.
• Limited proprietary molecule portfolio: Unlike the top-five manufacturers who control extensive patent-protected active ingredient pipelines, Rainbow's core portfolio remains heavily weighted toward off-patent generics, making it vulnerable to price wars from other low-cost producers, particularly within China and India.
Read More ▼Show Less ▲
Strengths:
• Self-owned heavy-asset manufacturing base: Rainbow operates multi-10,000-tonne annual capacity synthesis plants at its Weifang Binhai mega-complex in Shandong, fully controlling the entire chain from technical-grade active ingredient production to downstream formulation compounding. This vertical integration captured a 31.68% gross margin on its direct B2C segment in 2025, far exceeding industry averages for pure formulators.
• Global direct-market penetration ('Model Farm' strategy): Through its unique 'Team + Platform + Innovation' model, Rainbow has bypassed traditional distribution channels to directly serve end-use farmers and retailers in 40+ countries. Its B2C segment revenue share climbed to 43.44% in 2025, transforming Rainbow from a backend supplier into a pricing-power brand in key markets across Latin America, Africa, and Asia.
• Strategic overseas asset acquisition: In 2025, Rainbow acquired Spanish agrochemical firm Sarabia S.A. for €32 million, gaining immediate EU manufacturing registration, established distribution networks, and a production foothold in one of the world's most regulated agricultural chemical markets—a gateway that would take a decade to build organically.
• Diversification beyond herbicides: While historically dominated by herbicides (70%+ of revenue), Rainbow achieved a breakthrough in 2025: insecticide and fungicide revenue share increased to 30.15%, and the newly launched 'RainbowBio' biological product line began commercialization across multiple continents, reducing business concentration risk.
Weaknesses:
• Extreme foreign exchange exposure: With 99.18% of revenue derived from outside China, Rainbow's earnings are acutely sensitive to RMB appreciation and currency volatility in key markets including Brazil (BRL), Argentina (ARS), and Nigeria (NGN), creating unpredictable margin compression risks.
• Limited proprietary molecule portfolio: Unlike the top-five manufacturers who control extensive patent-protected active ingredient pipelines, Rainbow's core portfolio remains heavily weighted toward off-patent generics, making it vulnerable to price wars from other low-cost producers, particularly within China and India.
Business Nature
Core Business Areas
Industry Rankings
Corporate Report
VerityRank Score
Based on market presence, financial scale, operational capacity, and brand strength.
Quick Facts
Headquarters
Jinan/Weifang, Shandong, China
Founded
2005
Employees
4,200+
Factories
China: Weifang Binhai Economic Development Zone mega-complex (Shandong, multi-10,000-ton annual capacity), multiple synthesis and formulation plants; Spain: Sarabia S.A. (acquired 2025, €32 million); United States: wholly-owned subsidiary with local manufacturing; 10+ production facilities with full active ingredient synthesis and formulation capabilities
Listing
Shenzhen Stock Exchange (SZSE: 301035)
Categories
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website Shenzhen Stock Exchange (SZSE: 301035) , Rainbow Chemical Official | Sarabia Acquisition (Xinhua Silk Road) | 2025 Annual Results | Semi-Annual Report 2024 | SZSE Listing Information
